My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Carcinogen risk assessment guidelines and children.

    Buffler PA, Kyle AD.

    Environ Health Perspect. 1999 Jun;107(6):A286-8. No abstract available. PMID: 10339455 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The role of mode of action studies in extrapolating to human risks in toxicology.

    Lock EA, Smith LL.

    Toxicol Lett. 2003 Apr 11;140-141:317-22. Review.PMID: 12676480 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds.

    Andersen ME, Meek ME, Boorman GA, Brusick DJ, Cohen SM, Dragan YP, Frederick CB, Goodman JI, Hard GC, O'Flaherty EJ, Robinson DE.

    Toxicol Sci. 2000 Feb;53(2):159-72.PMID: 10696764 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.

    Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, van Gemert M.

    Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. Review.PMID: 10388618 [PubMed - indexed for MEDLINE]Related articles

    5.

    Analysis of in vivo mutation data can inform cancer risk assessment.

    Moore MM, Heflich RH, Haber LT, Allen BC, Shipp AM, Kodell RL.

    Regul Toxicol Pharmacol. 2008 Jul;51(2):151-61. Epub 2008 Feb 1.PMID: 18321622 [PubMed - indexed for MEDLINE]Related articles

    6.

    What to do at low doses: a bounding approach for economic analysis.

    Griffiths CW, Dockins C, Owens N, Simon NB, Axelrad DA.

    Risk Anal. 2002 Aug;22(4):679-88.PMID: 12224742 [PubMed - indexed for MEDLINE]Related articles

    7.

    U.S. Environmental Protection Agency's revised guidelines for carcinogen risk assessment: evaluating a postulated mode of carcinogenic action in guiding dose-response extrapolation.

    Wiltse JA, Dellarco VL.

    Mutat Res. 2000 Jan 3;464(1):105-15.PMID: 10633182 [PubMed - indexed for MEDLINE]Related articles

    8.

    Adjusting for youth: updated cancer risk guidelines.

    Schmidt CW.

    Environ Health Perspect. 2003 Oct;111(13):A708-11. No abstract available. PMID: 14527861 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Chloroform: An EPA test case.

    Schmidt CW.

    Environ Health Perspect. 1999 Jul;107(7):A358-60.PMID: 10379014 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Key issues in carcinogen risk assessment guidelines, Society for Risk Analysis.

    Anderson E, Deisler PF Jr, McCallum D, Hilaire CS, Spitzer HL, Strauss H, Wilson JD, Zimmerman R.

    Risk Anal. 1993 Aug;13(4):379-82. No abstract available. PMID: 8234945 [PubMed - indexed for MEDLINE]Related articles

    11.

    A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data.

    Dellarco VL, Baetcke K.

    Toxicol Sci. 2005 Jul;86(1):1-3. No abstract available. PMID: 15939704 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Assessing cancer risks from short-term exposures in children.

    Ginsberg GL.

    Risk Anal. 2003 Feb;23(1):19-34. Review.PMID: 12635720 [PubMed - indexed for MEDLINE]Related articles

    13.

    The European total ban on human cloning: an analysis of the Council of Europe's actions in prohibiting human cloning.

    Somekh N.

    Boston Univ Int Law J. 1999 Fall;17(2):397-423. No abstract available. PMID: 12465645 [PubMed - indexed for MEDLINE]Related articles

    14.

    Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation.

    Roberts RA, Crump KS, Lutz WK, Wiegand HJ, Williams GM, Harrison PT, Purchase IF.

    Arch Toxicol. 2001 Nov;75(9):507-12.PMID: 11760810 [PubMed - indexed for MEDLINE]Related articles

    15.

    EPA assesses cancer risk due to childhood carcinogen exposure.

    Lindsey H.

    Lancet Oncol. 2003 Apr;4(4):201. No abstract available. PMID: 12681256 [PubMed - indexed for MEDLINE]Related articles

    16.

    Universal declaration on the human genome and human rights (revised draft).

    Unesco.

    Bull Med Ethics. 1997 Mar;No. 126:9-11. No abstract available. PMID: 11660552 [PubMed - indexed for MEDLINE]Related articles

    17.

    An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.

    McCarroll N, Keshava N, Cimino M, Chu M, Dearfield K, Keshava C, Kligerman A, Owen R, Protzel A, Putzrath R, Schoeny R.

    Environ Mol Mutagen. 2008 Mar;49(2):117-31. Review.PMID: 18240158 [PubMed - indexed for MEDLINE]Related articles

    18.

    A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.

    Butterworth BE.

    Regul Toxicol Pharmacol. 2006 Jun;45(1):9-23. Epub 2006 Mar 10.PMID: 16530901 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Delaney debate is losing focus.

    Orme TW.

    Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 1):371-4. No abstract available. PMID: 7724840 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).

    Roberts SM, Jordan KE, Warren DA, Britt JK, James RC.

    Regul Toxicol Pharmacol. 2002 Feb;35(1):44-55. Review.PMID: 11846635 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity